Total Payments
$101,790
2024 Payments
$242.13
Companies
17
Transactions
126
Medicare Patients
1,607
Medicare Billing
$200,310
Payment Breakdown by Category
Other$52,375 (51.5%)
Education$24,277 (23.9%)
Travel$12,752 (12.5%)
Consulting$8,600 (8.4%)
Food & Beverage$3,589 (3.5%)
Gifts$197.39 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $52,375 | 14 | 51.5% |
| Education | $24,277 | 10 | 23.9% |
| Travel and Lodging | $12,752 | 34 | 12.5% |
| Consulting Fee | $8,600 | 2 | 8.4% |
| Food and Beverage | $3,589 | 65 | 3.5% |
| Gift | $197.39 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Progenics Pharmaceuticals, Inc. | $60,608 | 52 | $0 (2023) |
| Intuitive Surgical, Inc. | $32,807 | 43 | $0 (2023) |
| PFIZER INC. | $7,507 | 6 | $0 (2018) |
| Boston Scientific Corporation | $162.84 | 3 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $125.00 | 1 | $0 (2018) |
| Bayer HealthCare Pharmaceuticals Inc. | $116.14 | 1 | $0 (2017) |
| Myriad Genetic Laboratories, Inc. | $106.11 | 2 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $85.81 | 5 | $0 (2024) |
| ABBVIE INC. | $43.99 | 2 | $0 (2024) |
| Merck Sharp & Dohme LLC | $39.03 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $242.13 | 13 | Ferring Pharmaceuticals Inc. ($85.81) |
| 2023 | $50,386 | 60 | Progenics Pharmaceuticals, Inc. ($37,391) |
| 2022 | $33,887 | 28 | Progenics Pharmaceuticals, Inc. ($23,058) |
| 2021 | $352.01 | 5 | Intuitive Surgical, Inc. ($192.63) |
| 2020 | $9,031 | 6 | Intuitive Surgical, Inc. ($9,031) |
| 2019 | $84.61 | 3 | ROCHESTER MEDICAL CORPORATION ($31.36) |
| 2018 | $7,632 | 7 | PFIZER INC. ($7,507) |
| 2017 | $174.62 | 4 | Bayer HealthCare Pharmaceuticals Inc. ($116.14) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: ONCOLOGY | ||||||
| 09/29/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $29.70 | General |
| Category: Oncology | ||||||
| 09/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/14/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 03/25/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: ONCOLOGY | ||||||
| 03/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: ONCOLOGY | ||||||
| 02/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/20/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: ONCOLOGY | ||||||
| 01/23/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Education | In-kind items and services | $13.19 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2023 | Myriad Genetic Laboratories, Inc. | — | Food and Beverage | In-kind items and services | $92.37 | General |
| 10/23/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/23/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/23/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Travel and Lodging | In-kind items and services | $790.94 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/23/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Travel and Lodging | In-kind items and services | $194.38 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/23/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $84.43 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/23/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/14/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/14/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Travel and Lodging | In-kind items and services | $498.90 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/14/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Travel and Lodging | In-kind items and services | $167.55 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/14/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $115.21 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 09/14/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Travel and Lodging | In-kind items and services | $79.12 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 176 | 190 | $49,959 | $13,741 |
| 2022 | 15 | 506 | 641 | $331,595 | $69,084 |
| 2021 | 17 | 527 | 640 | $342,371 | $80,286 |
| 2020 | 14 | 398 | 487 | $161,070 | $37,199 |
Total Patients
1,607
Total Services
1,958
Medicare Billing
$200,310
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 25 | 25 | $8,000 | $2,619 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 37 | 39 | $8,619 | $2,378 | 27.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 30 | $5,745 | $1,897 | 33.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 24 | 26 | $5,460 | $1,896 | 34.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $5,115 | $1,636 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,400 | $1,429 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 20 | $2,820 | $1,027 | 36.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 13 | 14 | $9,632 | $828.08 | 8.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 14 | $168.00 | $30.80 | 18.3% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 17 | 17 | $99,229 | $18,718 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 121 | 162 | $35,802 | $11,705 | 32.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 43 | 43 | $19,995 | $6,392 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 43 | 57 | $18,240 | $6,340 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 43 | 43 | $15,781 | $4,349 | 27.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 42 | 63 | $42,084 | $4,020 | 9.6% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2022 | 11 | 11 | $30,008 | $3,037 | 10.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2022 | 30 | 39 | $8,190 | $2,908 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 42 | 56 | $7,896 | $2,898 | 36.7% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 19 | 19 | $13,547 | $1,971 | 14.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 31 | 40 | $5,880 | $1,810 | 30.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 18 | 20 | $5,040 | $1,600 | 31.7% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 12 | 13 | $24,211 | $1,529 | 6.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 20 | 44 | $4,180 | $1,442 | 34.5% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2022 | 14 | 14 | $1,512 | $365.06 | 24.1% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2021 | 22 | 22 | $128,414 | $26,637 | 20.7% |
About Dr. Andrew Stephenson, MD
Dr. Andrew Stephenson, MD is a Urology healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366478455.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Stephenson, MD has received a total of $101,790 in payments from pharmaceutical and medical device companies, with $242.13 received in 2024. These payments were reported across 126 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($52,375).
As a Medicare-enrolled provider, Stephenson has provided services to 1,607 Medicare beneficiaries, totaling 1,958 services with total Medicare billing of $200,310. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology, Urology
- Location Syracuse, NY
- Active Since 06/23/2006
- Last Updated 11/03/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1366478455
Products in Payments
- PYLARIFY (Drug) $60,608
- Da Vinci Surgical System (Device) $27,643
- XTANDI (Drug) $7,507
- DA VINCI SP (Device) $4,164
- DAVINCI XI (Device) $1,000
- LithoVue (Device) $131.66
- Erleada (Drug) $125.00
- Xofigo (Drug) $116.14
- ADSTILADRIN (Biological) $85.81
- BOTOX (Biological) $43.99
- KEYTRUDA (Biological) $39.03
- BMD-Brachysource I-25 seed (Device) $35.15
- GENERAL KIDNEY STONE DISEASE (Device) $31.18
- ILLUCCIX (Drug) $29.86
- ERLEADA (Drug) $29.70
- AirSeal (Device) $23.33
- (815) Thiola (Drug) $22.07
- GEMTESA (Drug) $17.14
- PROLARIS (Device) $13.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Syracuse
Christopher Pieczonka, M.d, M.D
Urology — Payments: $762,206
Urology $762,206
Dr. David Albala, M.d, M.D
Urology — Payments: $212,162
Urology $212,162
Dr. Scott Wiener, Md, MD
Urology — Payments: $43,281
Urology $43,281
Dr. Joseph Jacob, Md, MD
Urology — Payments: $36,165
Urology $36,165
Po Lam, Md, MD
Urology — Payments: $32,938
Urology $32,938
Ilija Aleksic, M.d, M.D
Urology — Payments: $16,486
Urology $16,486